These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3398650)

  • 1. Phenobarbital plasma level/dose ratio in monotherapy. Influence of age, sex and dose.
    Durán JA; Sánchez A; Serrano MI; Serrano JS
    Methods Find Exp Clin Pharmacol; 1988 May; 10(5):337-40. PubMed ID: 3398650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors modifying valproate plasma level/dose ratio: age, sex, dose and plasma level.
    Sánchez A; Durán JA; Abadín JA
    Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):583-6. PubMed ID: 2511386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and free valproic acid: plasma level/dose ratio in monotherapy.
    Abadín JA; Durán JA; Sánchez A; Serrano JS
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):221-5. PubMed ID: 2051846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of phenobarbital in epileptic children. Effect of combination with other anticonvulsants].
    Benedetti P; Antonozzi I; Curatolo P; Porro G
    Arch Fr Pediatr; 1979; 36(7):686-90. PubMed ID: 533347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma concentrations of phenobarbital and dosage according to age].
    Alix D; Berthou F; Riche C; Castel Y
    Dev Pharmacol Ther; 1984; 7 Suppl 1():164-70. PubMed ID: 6518958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the evaluation of plasma levels of primidone and phenobarbital].
    Franzoni E; Mambelli M; Masoni P; Govoni M
    Pediatr Med Chir; 1987; 9(5):599-600. PubMed ID: 3126490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum phenobarbital levels in epileptics].
    Loiseau P; Brachet A; Henry P
    Encephale; 1975; 1(4):341-57. PubMed ID: 1220957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of phenobarbital by the oral route in the acute and maintenance treatment of convulsions in children].
    Autret E; Billard C; Gold F; Laugier J; Breteau M
    Arch Fr Pediatr; 1983; 40(7):579-83. PubMed ID: 6639286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily dosing with phenobarbital in children with seizure disorders.
    Davis AG; Mutchie KD; Thompson JA; Myers GG
    Pediatrics; 1981 Dec; 68(6):824-7. PubMed ID: 7322718
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between age and plasma level/dosage ratio for phenobarbital in infants and children.
    Rossi LN; Nino LM; Principi N
    Acta Paediatr Scand; 1979 May; 68(3):431-4. PubMed ID: 443043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenobarbital doses necessary to achieve 'therapeutic' concentrations in children.
    Suzuki Y; Cox S; Hayes J; Walson PD
    Dev Pharmacol Ther; 1991; 17(1-2):79-87. PubMed ID: 1811924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of the intravenous route for the use of phenobarbital in asphyxiated full term newborn infants].
    Gold F; Bourin M; Granry JC; Amine A; Breteau M; Laugier J
    Arch Fr Pediatr; 1979 Jun; 36(6):610-6. PubMed ID: 526116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of malaria prophylaxis using a single dose of chloroquine at different intervals in an endemic malarious area.
    Karunakaran CS
    J Trop Med Hyg; 1980 Oct; 83(5):195-201. PubMed ID: 7001039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
    Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
    Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.